Dr. Mital Patel

Dr. Mital Patel

Assistant Professor

Qualification: M.Pharm, Ph.D.

Specialization: Pharmaceutical Science

E-mail: mital.patel@nmims.edu

Phone: 022-42332000 (Ext- 2027)

Experience: Academics 7 years

A dedicated researcher and educator, she specialises in formulation development, quantum sensing, and drug compatibility studies, with a strong emphasis on quality assurance and regulatory science. She is an expert in LC–MS/MS, impurity profiling, Quality by Design (QbD), and the application of multivariate models in pharmaceutical research. Notably, she has authored two Q1 high-impact-factor publications, including work in Trends and in journals indexed in the Journal Citation Reports (JCR), underscoring her commitment to advancing pharmaceutical sciences.

Interest areas:

• Quality assurance and Pharmaceutical Analysis
• Nitrosamine Quantification & Impurity Profiling (LC-MS/MS, MS, NMR, FTIR)
• Isolation and Characterization of Compounds
• Formulation development and Characterisation
• Compatibility study
• Metabolomics
• Quantum sensing

 Research

• Publications – Total number (International- 38 , National- 1)
• Book Chapters- Total number (4)
• Presentations- Total number (International- 8 , National- 6)
• Patent (Published) - 1

Grant: SVKM’S NMIMS Seed grant – 1,00,000 - Comprehensive chemical degradation behaviour of selected anticancer drug- An Impurity Profiling (Completed)

Conferences/Workshops/Seminars attended- 12

Academic activities

She has successfully guided more than sixteen M.Pharm. Her two MPharm QA student got "Best Thesis Award- Mpharm Quality Assurance”.

Awards

• Received "Certificate of Appreciation” and awarded first prize with 3700 cash in the event for "Innovative Idea challenge”, organized by BNCP and co-hosted by Mumbai university, 28-30 September 2020.
• Recipient of " P. D. Sethi memorial annual award 2017, Certificate of Merit”, Best research paper on application of TLC/HPTLC in pharma, herbal and other chemical analysis.

Professional Memberships

• Registered Pharmacist of Gujarat State Pharmacy Council
• Life Member of the Association of Pharmaceutical Teachers of India

Recent Publications

• Vadnere, N., Bherje, S., & Patel, M. (2025). Sustainability assessment of PDE-5 inhibitor analysis: A comparative study using AGREE, AGREEPrep, Complex GAPI, and BAGI. Trends in Environmental Analytical Chemistry. https://doi.org/10.1016/j.teac.2025.e00273 (Impact Factor: 13.4)
• Dhas, M., Pastagia, A., Sharma, A., Khera, R., Kudarha, S., Kulkarni, S., Soman, S., Mutalik, S., Barnwal, R. P., Singh, G., & Patel, M. (2022). Organic quantum dots: An ultrasmall nanoplatform for cancer theranostics. Journal of Controlled Release, 348, 798–824. https://doi.org/10.1016/j.jconrel.2022.06.033 (Impact Factor: 11.47)
• Maliyakal, J., & Patel, M. (2025). Green chemistry approaches in the analytical validation of fosravuconazole using UV spectrophotometry and RP-HPLC. Green Analytical Chemistry, 100215. https://doi.org/10.1016/S2772577425000126 (Impact Factor: 6.2)
• Vadnere, N., Alavala, R. R., & Patel, M. (2025). Comprehensive LC-MS/MS profiling, toxicity assessment, and molecular docking analysis of vibegron degradation products. Microchemical Journal. https://doi.org/10.1016/j.microc.2025.114775
• Nahata, A., Patel, M., & Muchakayal, S. (2024). Strategic approaches to elevate quality and sustainability in drug development: Comprehensive Pretomanid (PA-824) chemical stability study using QbD and green chemistry principles. Microchemical Journal, 200, 110413. https://doi.org/10.1016/S0026265X24005253 (Impact Factor: 4.8)
• Mulla, S. J., & Patel, M. (2025). Global regulatory perspectives on sensor-enabled and biomaterial-integrated medical devices: A focus on India, Canada, and Australia. Biomed Mater Devices. https://doi.org/10.1007/s44174-025-00327-z (Impact Factor: 4.4)
• Vadnere, N., & Patel, M. (2025). UV spectrophotometry and HPLC quantification of vibegron: Evaluating whiteness, greenness, and blueness. Accreditation and Quality Assurance. https://doi.org/10.1007/s00769-025-01655-9 (Impact Factor: 1.0)